US 11518772
Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
granted A61KA61K31/5383A61P
Quick answer
US patent 11518772 (Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors) held by NIKANG THERAPEUTICS, INC. expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- NIKANG THERAPEUTICS, INC.
- Grant date
- Tue Dec 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/5383, A61P, A61P35/00